Clarus Wealth Advisors Novartis Ag Transaction History

Clarus Wealth Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 11, 2019	BUY	$85.54 - $94.26 $429,924 - $473,750	5,026 Added 587.84%	5,881 $511,000
Q1 2019 Apr 04, 2019	BUY	$75.32 - $86.15 $677 - $775	9 Added 1.06%	855 $82,000
Q4 2018 Jan 08, 2019	BUY	$73.66 - $82.02 $62,316 - $69,388	846 New	846 $73,000
Q4 2018 Jan 07, 2019	SELL	$73.66 - $82.02 $62,316 - $69,388	-846 Closed	0 $0
Q3 2018 Oct 03, 2018	BUY	$66.94 - $77.43 $1,004 - $1,161	15 Added 1.81%	846 $73,000
Q2 2018 Jul 05, 2018	BUY	$64.91 - $73.36 $53,940 - $60,962	831 New	831 $67,000

1,439

135M

1.12M

1.82M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $229B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Clarus Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Clarus Wealth Advisors with notifications on news.